Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25008 | 22249092 | Saudi J Gastroenterol | The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children. | 2012 | Details |
| A25011 | 22237875 | JPEN J Parenter Enteral Nutr | Nonalcoholic fatty liver disease in pediatric patients. | 2012 | Details |
| A25012 | 22228878 | Ann Hepatol | The burden of hepatic encephalopathy in Latin America. | 2011 | Details |
| A25013 | 22247604 | J Clin Biochem Nutr | Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. | 2011 | Details |
| A25014 | 22246806 | Mol Cell Biochem | Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK/ATF4/CHOP signaling pathway. | 2012 | Details |
| A25015 | 22246329 | Eur J Gastroenterol Hepatol | The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population. | 2012 | Details |
| A25016 | 22245962 | Clin Gastroenterol Hepatol | Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. | 2012 | Details |
| A25017 | 22245895 | J Hepatol | Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. | 2012 | Details |
| A25018 | 22242926 | Metab Syndr Relat Disord | Docosahexaenoic acid prevents trans-10, cis-12-conjugated linoleic acid-induced nonalcoholic fatty liver disease in mice by altering expression of hepatic genes regulating fatty acid synthesis and oxidation. | 2012 | Details |
| A25020 | 22240370 | Clin Hemorheol Microcirc | Elevated hematocrit in nonalcoholic fatty liver disease: a potential cause for the increased risk of cardiovascular disease? | 2012 | Details |
| A25021 | 22240297 | J Proteomics | Changes in hepatic protein expression in spontaneously hypertensive rats suggest early stages of non-alcoholic fatty liver disease. | 2012 | Details |
| A25022 | 22239839 | Dan Med J | Low incidence of non-alcoholic steatohepatitis in a Danish liver unit. | 2012 | Details |
| A25023 | 22239625 | Curr Vasc Pharmacol | Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options. | 2012 | Details |
| A25024 | 22239319 | Obes Rev | Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men. | 2012 | Details |
| A25025 | 22238690 | PLoS One | Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver. | 2012 | Details |
| A25026 | 22236001 | Clin Exp Immunol | Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells. | 2012 | Details |
| A25027 | 22235218 | Hepat Mon | Comparison of portal vein doppler indices and hepatic vein doppler waveform in patients with nonalcoholic fatty liver disease with healthy control. | 2011 | Details |
| A25030 | 22229957 | Int J Food Sci Nutr | Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A25031 | 22228717 | Diabetes | TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice. | 2012 | Details |
| A25032 | 22228550 | J Clin Immunol | The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis. | 2012 | Details |
| A25033 | 22228470 | J Cell Biochem | Activation of PKR/eIF2α signaling cascade is associated with dihydrotestosterone-induced cell cycle arrest and apoptosis in human liver cells. | 2012 | Details |
| A25034 | 22227333 | Eur J Pharmacol | Flavangenol (pine bark extract) and its major component procyanidin B1 enhance fatty acid oxidation in fat-loaded models. | 2011 | Details |
| A25035 | 22227283 | Prev Med | Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling. | 2011 | Details |
| A25037 | 22227046 | Arch Med Res | Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease. | 2012 | Details |
| A25038 | 22224077 | Hepat Mon | Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease. | 2011 | Details |
| A25039 | 22223573 | J Nutr | Long-term dietary potential renal acid load during adolescence is prospectively associated with indices of nonalcoholic fatty liver disease in young women. | 2012 | Details |
| A25040 | 22221818 | Liver Int | The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. | 2011 | Details |
| A25041 | 22221544 | BMC Gastroenterol | Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. | 2012 | Details |
| A25042 | 22221448 | Lipids Health Dis | Dietary restriction, caloric value and the accumulation of hepatic fat. | 2012 | Details |
| A25043 | 22221411 | Lipids Health Dis | Palmitic and linoleic acids induce ER stress and apoptosis in hepatoma cells. | 2012 | Details |
| A25044 | 22221215 | Nutr Rev | Therapeutic potential of green tea in nonalcoholic fatty liver disease. | 2012 | Details |
| A25045 | 22219597 | World J Gastroenterol | Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. | 2011 | Details |
| A25047 | 22215946 | World J Gastroenterol | IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice. | 2011 | Details |
| A25048 | 22215535 | IUBMB Life | Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor. | 2012 | Details |
| A25049 | 22215515 | Toxicol Pathol | Mice deficient in glycerol-3-phosphate acyltransferase-1 have a reduced susceptibility to liver cancer. | 2012 | Details |
| A25050 | 22213436 | Hepatology | Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. | 2012 | Details |
| A25051 | 22213086 | Hepatology | Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. | 2012 | Details |
| A25053 | 22210573 | Diabetes Care | Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. | 2011 | Details |
| A25054 | 22209939 | Biochim Biophys Acta | Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement. | 2011 | Details |
| A25055 | 22209679 | Clin Nutr | Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes. | 2011 | Details |
| A25056 | 33907358 | J Proteomics Bioinform | High Fat Diet-Induced Changes in Hepatic Protein Abundance in Mice. | 2012 | Details |
| A25057 | 27326050 | Heart Asia | Non-alcoholic fatty liver disease and outcomes in persons with acute coronary syndromes: insights from the GRACE-ALT analysis. | 2012 | Details |
| A25058 | 24829632 | Middle East J Dig Dis | Common Digestive and Liver Diseases among 5880 Patients Admitted to Shariati Hospital,Tehran,Iran during 2000-2009. | 2012 | Details |
| A25060 | 24713803 | Ann Gastroenterol | Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic. | 2012 | Details |
| A25061 | 24713801 | Ann Gastroenterol | Non-alcoholic fatty liver disease may develop in individuals with normal body mass index. | 2012 | Details |
| A25062 | 24436572 | Curr Trends Endocinol | Fatty acid metabolism and thyroid hormones. | 2012 | Details |
| A25063 | 24331173 | Obes Res Clin Pract | Hepatic tumor necrosis factor-α, leptin and adiponectin expression in morbid obese patients: Clinicopathological correlations. | 2013 | Details |
| A25064 | 24024115 | Mol Metab | Obesity and the gut microbiome: Striving for causality. | 2012 | Details |
| A25065 | 23930060 | Hippokratia | Fatty liver disease in an autopsy series of children and adolescents. | 2012 | Details |
| A25066 | 23750438 | Przegl Lek | [Nonalcoholic fatty liver disease as a risk factor of macroangiopahty in patients with type 2 diabetes]. | 2012 | Details |
| A25067 | 22201932 | Front Biosci (Elite Ed) | Influence of lifestyle habits, nutritional status and insulin resistance in NAFLD. | 2012 | Details |
| A25068 | 22198578 | Clin Biochem | Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response. | 2011 | Details |
| A25069 | 22197855 | J Pediatr Gastroenterol Nutr | Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. | 2012 | Details |
| A25070 | 22197629 | Dig Liver Dis | Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. | 2011 | Details |
| A25071 | 22196506 | J Acupunct Meridian Stud | Ayurvedic formulation of Liv-Pro-08 reduces nonalcoholic fatty liver disease in rats fed with high-fat diet. | 2011 | Details |
| A25072 | 22194737 | Exp Diabetes Res | The role of metformin in the management of NAFLD. | 2011 | Details |
| A25073 | 22190925 | Int J Endocrinol | Intrauterine growth retardation and nonalcoholic Fatty liver disease in children. | 2011 | Details |
| A25074 | 22190000 | Eur J Endocrinol | Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat. | 2011 | Details |
| A25075 | 22189171 | Diabetes Res Clin Pract | Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease? | 2011 | Details |
| A25076 | 22188204 | J Gastroenterol Hepatol | CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: superparamagnetic iron oxide-magnetic resonance image and pathologic correlation. | 2012 | Details |
| A25078 | 22187656 | J Lipids | Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target. | 2011 | Details |
| A25079 | 22184802 | MMW Fortschr Med | [Omega-3 fatty acids as an option in the treatment of NAFLD]. | 2011 | Details |
| A25080 | 22156481 | Digestion | Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area. | 2011 | Details |
| A25081 | 22183968 | Hepatology | Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. | 2012 | Details |
| A25082 | 22183953 | Hepatology | Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats. | 2012 | Details |
| A25083 | 22183915 | Hepatology | Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. | 2012 | Details |
| A25084 | 22183894 | Mol Med | Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis. | 2012 | Details |
| A25085 | 22183820 | Dig Dis Sci | Prevalence of hypothyroidism in nonalcoholic fatty liver disease. | 2011 | Details |
| A25086 | 22183689 | Hepatology | Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A25087 | 22183113 | Curr Opin Infect Dis | From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management. | 2012 | Details |
| A25088 | 22182810 | Dis Markers | SREBP-2 1784 G/C genotype is associated with non-alcoholic fatty liver disease in north Indians. | 2011 | Details |
| A25089 | 22182015 | Scand J Gastroenterol | Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. | 2011 | Details |
| A25090 | 22181832 | Intern Med J | Relationship between non-alcoholic fatty liver disease and pulmonary function. | 2012 | Details |
| A25092 | 22180989 | Bratisl Lek Listy | Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes? | 2011 | Details |
| A25093 | 22179204 | Mol Med Rep | Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. | 2011 | Details |
| A25094 | 22176347 | Hepatol Res | High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism. | 2011 | Details |
| A25095 | 22175908 | Hepatol Res | Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients. | 2011 | Details |
| A25097 | 22173246 | Singapore Med J | Metabolic syndrome. | 2011 | Details |
| A25098 | 22173168 | J Hepatol | The interaction of hepatic lipid and glucose metabolism in liver diseases. | 2011 | Details |
| A25099 | 22173167 | J Hepatol | Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. | 2011 | Details |
| A25100 | 22173165 | J Hepatol | Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets. | 2011 | Details |
| A25101 | 22170794 | Eur J Endocrinol | Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. | 2011 | Details |
| A25102 | 22169693 | Zhonghua Yu Fang Yi Xue Za Zhi | [Waist circumference reference values in Beijing versus the national values in detecting cardiovascular risk factors in 7-18 years old children]. | 2011 | Details |
| A25103 | 22168074 | Eksp Klin Gastroenterol | [Elastography efficiency in the liver fibrosis determination in patients with nonalcoholic fatty liver disease]. | 2011 | Details |
| A25104 | 22168073 | Eksp Klin Gastroenterol | [Comparison of the immune response in patients with alcoholic liver disease and non-alcoholic steatohepatitis]. | 2011 | Details |
| A25107 | 22166573 | Ann Hepatol | An unusual cause of cancer mimicry following liver transplantation. | 2012 | Details |
| A25108 | 22166564 | Ann Hepatol | Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin. | 2012 | Details |
| A25109 | 22166563 | Ann Hepatol | Serum homocysteine levels in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A25110 | 22165986 | Lipids Health Dis | Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease. | 2011 | Details |
| A25111 | 22162978 | Clin Lipidol | Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease. | 2011 | Details |
| A25112 | 22161114 | Obes Surg | Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients. | 2012 | Details |
| A25113 | 22160635 | Dig Dis Sci | Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD. | 2011 | Details |
| A25114 | 22157924 | J Pediatr Gastroenterol Nutr | LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease. | 2012 | Details |
| A25115 | 22157544 | J Nutr | Green tea extract suppresses NFκB activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis. | 2011 | Details |
| A25116 | 22157234 | Eur J Gastroenterol Hepatol | Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology. | 2012 | Details |
| A25117 | 22156706 | QJM | Prevalence and markers of advanced liver disease in type 2 diabetes. | 2011 | Details |
| A25118 | 22155853 | Hepatogastroenterology | Non-alcoholic fatty liver disease adversely affects the glycemic control afforded by sitagliptin. | 2012 | Details |
| A25119 | 22155365 | Gastroenterology | Autophagy protects cells from HCV-induced defects in lipid metabolism. | 2011 | Details |
| A25120 | 22155236 | Biochem Biophys Res Commun | Theaflavin attenuates ischemia-reperfusion injury in a mouse fatty liver model. | 2011 | Details |
| A25121 | 22154950 | Dig Liver Dis | Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients. | 2011 | Details |